Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis

[1]  W. Krol,et al.  Inhibition of Inflammatory Response by Artepillin C in Activated RAW264.7 Macrophages , 2013, Evidence-based complementary and alternative medicine : eCAM.

[2]  J. M. Sforcin,et al.  Brazilian Propolis Antileishmanial and Immunomodulatory Effects , 2013, Evidence-based complementary and alternative medicine : eCAM.

[3]  M. Kucharzewski,et al.  Stan Scheller: The Forerunner of Clinical Studies on Using Propolis for Poor and Chronic Nonhealing Wounds , 2013, Evidence-based complementary and alternative medicine : eCAM.

[4]  Hyejung Lee,et al.  Development and Validation of Acupuncture Fear Scale , 2013, Evidence-based complementary and alternative medicine : eCAM.

[5]  J. A. Lombardi,et al.  Anti-inflammatory activity of Lychnophora passerina, Asteraceae (Brazilian "Arnica"). , 2011, Journal of ethnopharmacology.

[6]  D. C. Cara,et al.  Brazilian Green Propolis Inhibits Inflammatory Angiogenesis in a Murine Sponge Model , 2011, Evidence-based complementary and alternative medicine : eCAM.

[7]  L. Bonamin,et al.  Inflammatory Process Modulation by Homeopathic Arnica montana 6CH: The Role of Individual Variation , 2011, Evidence-Based Complementary and Alternative Medicine.

[8]  D. Đikić,et al.  Protective effects of propolis and related polyphenolic/flavonoid compounds against toxicity induced by irinotecan , 2010, Medical oncology.

[9]  F. Frézard,et al.  New delivery strategies for the old pentavalent antimonial drugs , 2010, Expert opinion on drug delivery.

[10]  M. Muz,et al.  GC-MS analysis and antileishmanial activities of two Turkish propolis types , 2010, Parasitology Research.

[11]  W. Cunha,et al.  In vitro antileishmanial, antiplasmodial and cytotoxic activities of phenolics and triterpenoids from Baccharis dracunculifolia D. C. (Asteraceae). , 2009, Fitoterapia.

[12]  F. Frézard,et al.  Pentavalent Antimonials: New Perspectives for Old Drugs , 2009, Molecules.

[13]  M. Silva,et al.  In vitro and in vivo antileishmanial activities of a Brazilian green propolis extract , 2008, Parasitology Research.

[14]  F. Frézard,et al.  Reduced Tissue Parasitic Load and Infectivity to Sand Flies in Dogs Naturally Infected by Leishmania (Leishmania) chagasi following Treatment with a Liposome Formulation of Meglumine Antimoniate , 2008, Antimicrobial Agents and Chemotherapy.

[15]  J. M. Sforcin,et al.  Propolis and the immune system: a review. , 2007, Journal of ethnopharmacology.

[16]  N. S. S. Magalhães,et al.  Lipossomas e suas aplicaes teraputicas: estado da arte , 2007 .

[17]  A. Mornar,et al.  In vivo study of propolis supplementation effects on antioxidative status and red blood cells. , 2007, Journal of ethnopharmacology.

[18]  D. C. Ayres,et al.  Effects of Brazilian propolis on Leishmania amazonensis. , 2007, Memorias do Instituto Oswaldo Cruz.

[19]  L. Leon,et al.  Activity of Brazilian and Bulgarian propolis against different species of Leishmania. , 2007, Memorias do Instituto Oswaldo Cruz.

[20]  S. D. Castro.  Propolis: Biological and Pharmacological Activities. Therapeutic Uses of This Bee-product , 2006 .

[21]  F. Frézard,et al.  Improved targeting of antimony to the bone marrow of dogs using liposomes of reduced size. , 2006, International journal of pharmaceutics.

[22]  J. M. Sforcin,et al.  Propolis: Effect of different concentrations, extracts and intake period on seric biochemical variables. , 2006, Journal of ethnopharmacology.

[23]  Jha Tk.  Drug unresponsiveness & combination therapy for kala-azar. , 2006 .

[24]  T. K. Jha.  Drug unresponsiveness & combination therapy for kala-azar. , 2006, The Indian journal of medical research.

[25]  D. C. O. Gomes,et al.  Intramuscular immunization with p36(LACK) DNA vaccine induces IFN-γ production but does not protect BALB/c mice against Leishmania chagasi intravenous challenge , 2005, Parasitology Research.

[26]  Frédéric Frézard,et al.  Lipossomas: propriedades físico-químicas e farmacológicas, aplicações na quimioterapia à base de antimônio , 2005 .

[27]  M. Ouellette,et al.  Thiol-induced reduction of antimony(V) into antimony(III): A comparative study with trypanothione, cysteinyl-glycine, cysteine and glutathione , 2003, Biometals.

[28]  Marcelo de Jesus,et al.  Antimoniais empregados no tratamento da leishmaniose: estado da arte , 2003 .

[29]  F. Gozzo,et al.  Pentavalent organoantimonial derivatives: two simple and efficient synthetic methods for meglumine antimonate , 2003 .

[30]  N. Ha,et al.  Activation of murine macrophage cell line RAW 264.7 by Korean propolis , 2002, Archives of pharmacal research.

[31]  J. M. Sforcin,et al.  ABSENCE OF SEASONAL EFFECT ON THE IMMUNOMODULATORY ACTION OF BRAZILIAN PROPOLIS ON NATURAL KILLER ACTIVITY , 2002 .

[32]  W. Solbach,et al.  The host response to Leishmania infection. , 2000, Advances in immunology.

[33]  P. Kaye,et al.  Destruction of follicular dendritic cells during chronic visceral leishmaniasis. , 1997, Journal of immunology.

[34]  M. Ikeda,et al.  Isolation and identification of compounds from Brazilian propolis which enhance macrophage spreading and mobility. , 1996, Biological & pharmaceutical bulletin.

[35]  M. Marcucci.  Propriedades Biológicas e Terapêuticas dos Constituintes Químicos da Própolis , 1996 .

[36]  J. Foekens,et al.  The MTT Tetrazolium Salt Assay Scrutinized: How to Use this Assay Reliably to Measure Metabolie Activity of Cell Cultures in vitro for the Assessment of Growth Characteristics, IC50-Values and Cell Survival , 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[37]  T. Nishina,et al.  Safety of propolis. Acute toxicity , 1994 .

[38]  M. McElrath,et al.  The dynamics of granuloma formation in experimental visceral leishmaniasis , 1988, The Journal of experimental medicine.

[39]  T. Boon,et al.  A limiting dilution assay for quantifying Leishmania major in tissues of infected mice , 1985, Parasite immunology.

[40]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[41]  Clive G. Wilson,et al.  Tissue distribution and fate of free and liposome-encapsulated [125Sb]sodium stibogluconate by gamma scinligraphy , 1983 .

[42]  R. Ward,et al.  The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis. , 1977, Transactions of the Royal Society of Tropical Medicine and Hygiene.